1. 1136PDDiscrepancy of tumor neoantigen burden between primary lesions and matched metastases in lung cancer. (23rd October 2018) Authors: Jiang, T; Zhou, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1348PDGenomic landscape and its correlation with TMB, CD8 TILs and PD-L1 expression in Chinese lung squamous cell carcinoma. (23rd October 2018) Authors: Zhou, C; Jiang, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 37P Chemokine receptor CCR2b expressing anti-Tn-MUC1 CAR-T cells enhanced anti-breast cancer activity. (15th December 2019) Authors: Lin, Y; Yin, H; An, H; Zhou, C; Zhou, L; Chen, S; McGowan, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 473PASTRIS global real world study of osimertinib in patients (pts) with EGFR T790M non-small cell lung cancer (NSCLC): Subpopulation analyses. (25th November 2018) Authors: Provencio, M; Cheema, P K; Vansteenkiste, J F; Cho, B C; Zhou, C; Yu, J; Martin, C; Park, K; He, Y; Hu, Y; Vicente, D; Miranda, M; Rigas, J; de Marinis, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 484PActivity of afatinib in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC and baseline brain metastases: Pooled analysis of three large phase IIIb trials. (24th November 2019) Authors: Gottfried, M; de Marinis, F; Tu, H; Laktionov, K K; Feng, J; Poltoratskiy, A; Zhao, J; Tan, E-H; Lee, V; Kowalski, D; Yang, C-T; Srinivasa, B; Passaro, A; Clementi, L; Tang, W; Huang, D C-L; Cseh, A; Park, K; Zhou, C; Wu, Y-L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 503PActivity of afatinib in patients (pts) with NSCLC harboring uncommon EGFR mutations: Pooled analysis of three large phase IIIB trials. (24th November 2019) Authors: Passaro, A; De Marinis, F; Tu, H; Laktionov, K K; Feng, J; Poltoratskiy, A; Zhao, J; Tan, E-H; Gottfried, M; Lee, V; Kowalski, D; Yang, C-T; Srinivasa, B; Clementi, L; Tang, W; Huang, D C-L; Cseh, A; Park, K; Zhou, C; Wu, Y-L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 511PAURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS). (25th November 2018) Authors: Zhou, C; Wang, M; Cheng, Y; Chen, Y; Zhao, Y; Shi, Y-K; Ahn, M-J; Lu, Y; Shi, M; Han, J-Y; Kim, S-W; Zhang, H-L; Chen, G; Li, H; Wang, J; Wu, Y-L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 512POsimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS study. (25th November 2018) Authors: Zhou, Q; Zhang, H; Jiang, L; Shi, Y; Chen, Y; Yu, J; Zhou, C; He, Y; Hu, Y; Liang, Z-A; Pan, Y; Zhuo, W; Song, Y; Wu, G; Chen, G; Lu, Y; Cheng, Y; Lu, S; Wang, J; Wu, Y L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 6ER-022 The development and clinical application of tpn control software led by pharmacists in cancer hospital. (2nd March 2018) Authors: Wang, Z; Shao, Y; Yang, G; Zhao, Q; Shi, L; Zhou, C; Peng, Y; Huang, P Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A novel maximum power point tracking technique with improved particle swarm optimization for proton exchange membrane fuel cell. Issue 1 (1st September 2022) Authors: Zhou, C; Liu, Z Y; Sun, Y N; Mao, L Journal: Journal of physics Issue: Volume 2347:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗